Articles
Permanent URI for this collection
Browse
Browsing Articles by Author "A, Kostyuk"
Now showing 1 - 3 of 3
Results Per Page
Sort Options
Item Metadata only PCV81 Cost-Effectiveness of Apixaban For Stroke Prevention In Atrial Fibrillation: An Kazakhstan Perspective(Value in Health, 2017-10-01) Kostyuk, A; Almadiyeva, A; Nurgozhin, T; A, KostyukApixaban, dabigatran, and rivaroxaban are 3 novel oral anticoagulants (NOACs) currently approved for stroke prevention in patients with atrial fibrillation (AF). Although warfarin remains the standard of care in Kazakhstan.The objective of this study was to evaluate the cost-effectiveness of apixaban against other NOACs and warfarin from the considering costs and savings for public payers perspective in KazakhstanItem Metadata only PHP18 Pharmaceutical Policies In Eurasian Economic Union Countries(Value in Health, 2016-11-01) Kostyuk, A; Nurgozhin, T; Akanov, A; A, KostyukEurasian Economic Union (EAEU) is an international integration economic union established by a treaty which was signed on 2014. The union includes Russia, Kazakhstan, Belarus, Armenia and Kyrgyzstan. By 2017, the EAEU will form a common pharmaceutical market. Markets for medical equipment will also be integrated. Our objective is to analyze which pharmaceutical policies EAEU countries applied during the financial crisis.Item Metadata only PHP348 Trends of Implementation of Hta In Kazakhstan(2015-11-01) Kostyuk, A; Akanov, A; Nurgozhin, T; Almadiyeva, A; A, Kostyuk